Member Info for Bella6532

Correction...sorry I did this earlier and a few more went through afterwards so I've updated todays figures...
Feb 15, 2022 7.57M 18.63%
Feb 14, 2022 5.19M -16.39%
Feb 11, 2022 3.77M -4.69%
Feb 10, 2022 3.63M -6.57%
Feb 09, 2022 1.99M 2.24%
Feb 08, 2022 6.17M -10.07%
Feb 07, 2022 2.08M -21.78%
Feb 04, 2022 1.72M 2.97%
Feb 03, 2022 5.92M 12.33%
Feb 02, 2022 1.78M 2.94%
Feb 01, 2022 1.62M -6.10%
Jan 31, 2022 1.95M -11.16%
Jan 28, 2022 4.83M 5.97%
Jan 27, 2022 1.77M 11.04%
Jan 26, 2022 964.21K 3.82%
Jan 25, 2022 1.23M 7.53%
Jan 24, 2022 1.68M -5.81%
Jan 21, 2022 1.34M 1.97%
Jan 20, 2022 1.01M -2.56%
Jan 19, 2022 1.38M -6.59%
Jan 18, 2022 3.30M 14.38%
Jan 17, 2022 1.71M -5.19%

for anyone who might be interested....
Day Volume Movement
Feb 15, 2022 7.29M 22.22%
Feb 14, 2022 5.19M -16.39%
Feb 11, 2022 3.77M -4.69%
Feb 10, 2022 3.63M -6.57%
Feb 09, 2022 1.99M 2.24%
Feb 08, 2022 6.17M -10.07%
Feb 07, 2022 2.08M -21.78%
Feb 04, 2022 1.72M 2.97%
Feb 03, 2022 5.92M 12.33%
Feb 02, 2022 1.78M 2.94%
Feb 01, 2022 1.62M -6.10%
Jan 31, 2022 1.95M -11.16%
Jan 28, 2022 4.83M 5.97%
Jan 27, 2022 1.77M 11.04%
Jan 26, 2022 964.21K 3.82%
Jan 25, 2022 1.23M 7.53%
Jan 24, 2022 1.68M -5.81%
Jan 21, 2022 1.34M 1.97%
Jan 20, 2022 1.01M -2.56%
Jan 19, 2022 1.38M -6.59%
Jan 18, 2022 3.30M 14.38%
Jan 17, 2022 1.71M -5.19%

Energyshares...reverse T/O might not be good for Avacta shareholders...

Hi Timster...he disappeared around 10th Jan...coincidence perhaps but one does tend to think he might have had connections with Med and/or Abing....

Energyshares...and no 'we know no reason for the SP drop' RNS...mmmm because there is a reason and it will be short lived to simply fill orders...

Southern Hemosphere now moving towards their Autumn/Winter...more likelihood cases will rise and new variants appearing...plus travel opening up...gulp!!!

Now the Govt is winding up their free testing and 23 Feb sees the extension given to a bunch of LFT producers coming to an end, wouldn't this now be a good time for the Govt to now focus on UK made, highly accurate tests which will still be needed by the Likes of the NHS. With restrictions being lifted and our direction of travel is towards Spring/Summer, the pressures are off all concerned allowing for lessons to be learnt and a regrouping of ideas/policies going forward into next Autumn/Winter. Covid has not gone away and it too will cough up the next variant in the not too distant future.
The question for Avacta now is, how much time and effort do they wish to put into redeveloping their LFT going forward...and is there a market for such a test or this testing technology in other areas. Are we at the beginning of a testing revolution or is it a case of well we learnt a lot but the company needs to focus elsewhere and move on.
The relaunch as and when, or even if, it comes should give us those answers as well as the Finals and how much income was generated...if they give us a breakdown.

Finally, when a company brings on a new financial house to conduct a three day road show to IIs you should be aware that such an event could lead to SP movements as has just been seen especially when it there are no new shares being issued as would be the case in a fundraiser. As I said before, where are the shares going to come from for those II's looking to seriously invest in volume...they are and have been going after yours and the LFT withdrawal RNS was the perfect destabiliser. These guys aren't dummies, they know many PIs invested in Avacta purely as a Covid play and once that play was taken put of the picture you became a target and easy pickings.

It's been and will continue to be a rocky rise but we have the markers (early H2) for trial update but there's much more which could be coming our way in the meantime. It's what they don't say that counts...look for the less obvious not the obvious...

More than £40bn wiped off London shares as fears build over Ukraine...

What's the chance Avacta will try to launch a Covid/Flu test...or is that a no go...
As Covid cases decline, flu rates will start to come back. In Fance there has been a big up tick in flu cases especially in small kiddies...

I still suspect this is all a direct result of the roadshows last week. If there are II orders in the background then they will want to fill them low so same II's see a nice return as soon as they let this bounce. The same happens with fundraisers. Price is dropped/discounted heavily to encourage investors...once deals are done and everyone is paid up and shares in hand woosh the SP takes a nice turn, usually on the back of plenty of good news...the upturn encourages PI's to buy and II's sell into the rise. Guys this will turn once they have your shares and you might not be able to get back in quickly.
As far as the PI shorters go, well, as happens all the time, they will get burnt...you are easy pickings for the back room guys. They will ping the SP like a pice of kn..ker elastic and off they will fly...
Sigh...

When are we going to stop selling business off to overseas concerns...geez...

I'm sure there are others on here who have seen this happen before with other shares when the SP seems to take a hit right after an II Investor Presentation...mmm!!! funny that...I did ask where hey were going to get the shares from to fill potential orders...
My guess is they are using the dip to get those shares to then sell at a higher price to II buyers. As soon as the transactions have all been completed then the price will take a nice up lift going into results helped along by the LFT relaunch. Then we will bobble along with several other bits of news until end June (thereabouts) and then H2 will start to become very interesting.
I don't believe we will be taken down much further as this might make Avacta too much of a T/O target.
For some this is not going to be an easy ride and will take some b**ls as we ride out the next few months.

Well...AS didn't look too happy today and no mention of the Roadshow/II Investors. He also made it clear that they don't anticipate any fundraise in the near term.
LFT sounds seems to be frustrating and will take a little longer to sort and then there's the regulators to convince.
Hey Ho...think I'll sleep this one off until mid 2022...

I suppose there could always be the chance that we have been granted approval predicated on the upcoming tweaks...
I wonder if the tweaks will allow our test to differentiate Covid from Flu...ie a positive will mean you have Covid and not Flu.

What's your bet they will extend it!!! sigh

Personally I think the relaunch of the LFT will help the SP as it is an immediate income generator. However, it the will depend on what orders from IIs may be being filled...price supression...!!!
For LTHs and IIs the real prize is anything revolving around cancer treatments but that will be a drain on cash/income for some time.
However on the sidelines we do have other licence deals which have and should continue to contribute to the bottom line.
So right now we are looking at near middle and long term income streams...a great position to be in I would say...

That might give you some idea of what their direction of travel was/is to be...Covid and Influenza!!!

'Based on Avacta Limited, the AffiRX trademark is used in the following business: Reagents for medical and scientific research. '

'Based on Avacta Limited, the AffiDX trademark is used in the following business: Medical testing apparatus, instruments and equipment; medical testing apparatus, instruments and equipment for the detection and diagnosis of Covid-19 and influenza; parts and fittings for all the aforesaid goods. , Diagnostic testing and analysis services; medical testing and analysis services; diagnostic testing and analysis services for Covid-19 and influenza; medical testing and analysis services for Covid-19 and influenza; advisory and information services relating to all the aforesaid. , Diagnostic testing materials; medical diagnostic tests; lateral flow diagnostic tests; diagnostic reagents; diagnostic testing materials, medical diagnostic tests, lateral flow diagnostic tests and diagnostic reagents all for the detection and diagnosis of Covid-19 and influenza; parts and fittings for all the aforesaid goods. , Mobile application software for medical diagnostics; mobile application software for the collection, analysis and reporting of diagnostic tests; mobile application software for the collection, analysis and reporting of diagnostic tests for Covid-19 and influenza. .'

Here you can compare the Classes they applied for which are different...

https://www.trademarkelite.com/uk/trademark/trademark-detail/UK00003519801/AffiDX

https://www.trademarkelite.com/uk/trademark/trademark-detail/UK00003536447/AffiRX
Perhaps it's more to do with the Animal side of the business?

Apologies, haven't had time to read last couple of days posts, so if this has been covered, please ignore...

As we all know, we have just had 3 days of roadshow for II's. This, again, as we all know is to generate investment.

1. They can invest simply by buying stock through the markets - but for a serious II looking for a relatively large chunk where is all that surplus stock going to come from? If they committed/placed an order during one of the roadshows at a designated price/price band, then someone is going to have to encourage a few sticky hands to release some.
For Avacta, simply encouraging II's to buy through the markets doesn't actually do anything really for Avacta financially.

2. If the LFT side of the business has basically gone 't*ts up' due to the UK Govt's testing fiasco and the expected revenue generation is not longer to be expected in the short to medium term then surely it would be better for Avacta to look at offering warrants to these potential II investors. That would be more of a win win for everyone. Especially if other sides of the business look like they might progress sooner rather than later and start to become more demanding on cash flow/needs. There is, of course, the possibility that the Diagnostics side isn't as dead as we think and there are other aspects to it which may be in play with regard to other diseases or other territories like the US.

I for one seriously hope Avacta see fit to issue an update next week, financial and/or otherwise to at least acknowledge that we little guys are important to them and need reassurances too.